4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-134078
Chief Commercial Officer acquired 37,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna Chief Commercial Officer | 2024-12-04 | Grant or award | +37,800 | 96,200 | D | ||
| Derivatives | |||||||
| Friedl-Naderer Johanna Chief Commercial Officer | 2024-12-04 | Grant or award · Stock option (right to buy) | +60,300 | 60,300 | D | ||
Loading xslF345X05/ownership.xml…